Searched for
NEURODEGENERATIVE DISEASES
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Sleeping over 8 hours daily? Senior Neurologist at Apollo Hospitals explains its underlying health issues and potential risksAre you sleeping more than 8 hours? New research has revealed that a study of nearly 500,000 people found a 'sweet spot' of 6.4 to 7.8 hour...
- Could protein 'traffic jams' be the key to understanding aging and Alzheimer's? Here's what Stanford scientists claimStanford University researchers have identified a breakdown in the cell's protein production system as a key factor in brain aging and cogn...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Scientists say this simple thing may reverse brain aging and restore memory in weeksScientists have developed an experimental nasal spray that shows promise in reversing brain aging. This treatment targets chronic inflammat...
- Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...
- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...
- Sleeping 7 to 8 hours may help protect your brain from dementia, says studyNew research reveals a sweet spot for sleep, suggesting 7 to 8 hours nightly can reduce dementia risk. This study, analyzing millions, also...
- High TPC levels! Dark, degraded oil found in popular fast food chain: Study explains its impact on your healthA recent food safety scare has put the spotlight on reused cooking oil risks after a KFC outlet in Kondapur, Hyderabad was reportedly found...
- The Creature That Can Regrow Its Entire BrainPlanarian flatworms possess remarkable brain regeneration capabilities, thanks to specialized neoblast stem cells that can differentiate in...
- No sugar, lifestyle change, 10,000 steps not enough against diabetes and BP risks, warns top doctor. He suggests adding 2 more things to your routineNeurologist Dr. Sudhir Kumar warns that common health efforts like daily walking and cutting sugar may offer a false sense of security. He ...
- Football players more likely to develop neurodegenerative disease: Lancet studyAccording to the Swedish study that covered 6,007 male football players who played in the Swedish top division between 1924 to 2019, goalke...
- Heading the ball could hurt your brainExperts suggest repetitive mild head trauma sustained through heading the ball could be the reason for football players at increased risk. ...
- Artificial intelligence can speed up and improve Alzheimer's diagnosis: StudyScientists at the UK's University of Sheffield's Neuroscience Institute examines how the routine use of AI in healthcare could help to reli...
- Suven Life secures product patent in JapanSuven Life said it has been granted "one process patent from Japan corresponding to the NCEs which are for the treatment of disorders assoc...
- Decoded: How defective brain cells spread Alzheimer's and Parkinson'sNeurodegenerative diseases may be linked to defective brain cells disposing toxic proteins making neighbouring cells sick.
- Suven Life Sciences gets patents for neurodegenerative drug in Canada and ChinaSuven Life Sciences said it has been granted two patents from Canada and one patent in China for a drug used in the treatment of neurodegen...
- Biopharmaceutical Suven Life Sciences gets patents for neurodegenerative drugWith these new patents for treatment of neurodegenerative diseases, Suven has a total of 18 granted patents from Mexico and 20 from Singapo...
- Suven Life Sciences granted patents for neurodegenerative drugWith these new patents, Suven has a total of 19 granted patents from Australia, 14 from Japan and 15 from Hong Kong.
- Suven Life Sciences shares zoom 20% on securing three product patentsAt the NSE, it soared 19.99% to Rs 209.15. Neurodegenerative diseases include Alzheimer's disease, Schizophrenia and Parkinson's disease.
Load More
